No black box warning on record for Propafenone Hydrochloride

As of the latest FDA labeling reviewed, Propafenone Hydrochloride (PROPAFENONE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Propafenone Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause new or worsened arrhythmias. Evaluate patients via ECG prior to and during therapy. (5.1) Propafenone hydrochloride may unmask Brugada or Brugada-like Syndrome. (4 , 5.2) Avoid use with other drugs that prolong the QT interval. (5.3) Avoid simultaneous use of propafenone with both a cytochrome P450 2D6 (CYP2D6) inhibitor and a 3A4 inhibitor (CYP3A4). (5.4) May

No black box warning on record for Propafenone Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause new or worsened arrhythmias. Evaluate patients via ECG prior to and during therapy. (5.1) Propafenone hydrochloride may unmask Brugada or Brugada-like Syndrome. (4 , 5.2) Avoid use with other drugs that prolong the QT interval. (5.3) Avoid simultaneous use of propafenone with both a cytochrome P450 2D6 (CYP2D6) inhibitor and a 3A4 inhibitor (CYP3A4). (5.4) May

Propafenone Hydrochloride Black Box Warning

No black box warning on record for Propafenone Hydrochloride

Other warnings & precautions

Propafenone Hydrochloride Black Box Warning

No black box warning on record for Propafenone Hydrochloride

Other warnings & precautions